External validation and clinical utility assessment of PREDICT v2.2 prognostic model in young, node-negative, systemic treatment-naïve breast cancer patients. (November 2022) - Wang, Y.; Dackus, G.M.; Broeks, A.; Giardiello, D.; Hauptmann, M.; Jóźwiak, K.; Koop, E.A.; Opdam, M.; Siesling, S.; Sonke, G.S.; Stathonikos, N.; ter Hoeve, N.D.; et al.